Table 2.
Clinical Variable | Patients, No. (%) | Statistical Test | ||
Clinical Stage | WT | NB | Sarcomas | |
I | 0 | 0 | 1 (10%) | Not applied |
II | 6 (43%) | 2 (20%) | 1 (10%) | |
III | 5 (36%) | 0 | 5 (50%) | |
IV | 3 (21%) | 8 (80%) | 2 (20%) | |
Unknow | 0 | 0 | 1 (10%) | |
Correlation cfDNA levels vs. tumor staging | ||||
I/II vs. III | p = 0.99 | - | p = 0.66 | Mann-Whitney test and Kruskal-Wallis test. |
I/II vs. IV | p = 0.99 | p = 0.18 | p = 0.05 | |
III vs. IV | p = 0.99 | - | p = 0.32 | |
Correlation cfDNA levels vs. tumor volume | ||||
p = 0.08 | p = 0.02 | p = 0.29 | Spearmen test. | |
cfDNA levels and metastasis vs. no-metastasis at diagnosis | ||||
p = 0.70 | # | p = 0.12 | Mann-Whitney test. # Statistics cannot be performed. |
|
cfDNA levels and metastasis vs. no-metastasis during treatment | ||||
p = 0.94 | # | p = 0.50 | Mann-Whitney test. # Statistics cannot be performed. |